About this episode

The episode discusses the significance of recent NYSE uplistings for cannabis companies and explores market reactions and future potential.

Trulieve & Glass House make history with the long awaited NYSE uplisting! So why doesn't anyone care? We discuss turning bullish and what's next! In this episode we are joined by Hirsh Jain of Ananda Strategy to discuss how much has happened in the last few weeks and why the market seems not to care. We discuss the set-up going into November and the potential upside in 2 cannabis names + risks to watch out for. & Finally share 3 top picks Thanks to Hirsh as always for his insights on the industry Connect with Hirsh: LinkedIn - ⁠ ⁠⁠⁠https://www.linkedin.com/in/hirsh-jain/⁠⁠⁠⁠ Twitter - ⁠ ⁠⁠⁠https://twitter.com/anandastrategy⁠⁠⁠⁠ Hirsh's Website - ⁠ ⁠⁠⁠https://anandastrategy.com/

Explore listener stats, chart rankings, contacts and more on the Cannabis Investing Network podcast page.